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For millions of years, microbes have coexisted with eukaryotic cells at the mucosal sur-
faces of vertebrates in a complex, yet usually harmonious symbiosis. An ever-expanding
number of reports describe how eliminating or shifting the intestinal microbiota has pro-
found effects on the development and functionality of the mucosal and systemic immune
systems. Here, we examine some of the mechanisms by which bacterial signals affect
immune homeostasis. Focusing on the strategies that microbes use to keep our immune
system healthy, as opposed to trying to correct the immune imbalances caused by dys-
biosis, may prove to be a more astute and efﬁcient way of treating immune-mediated
disease.
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INTRODUCTION
Higher organisms beneﬁt from their microbiota, which offers
nutritional and physiological advantages to the host in exchange
for a nutrient-rich habitat. Microbes (bacteria, archaea, viruses,
fungi, protozoans, etc.) reside on all mucosal surfaces of the body,
with the gut harboring by far the most numerous population.
Separating the microbial cells from the host is the intestinal bar-
rier, which serves as an interface for many complex interactions.
Two major components of the intestinal barrier are the intestinal
epithelium and the gut associated lymphoid tissue (GALT). This
tissue has the challenging dual task of selectively absorbing nutri-
ents from the intestinal lumen, while preventing microbial entry
and infection. The majority of microbes that reside in the intestine
are commensals and do not pose a threat to the host under normal
conditions. Thus, the host’s immune system must learn to tolerate
this enormous commensal antigenic load. One of the strategies
that the host utilizes to avoid an inﬂammatory response against
the microbiota is to remain “ignorant” to a portion of the micro-
bial antigens, by using the intestinal barrier, including the mucous
layer and immunoglobulin (Ig) A, to maintain these antigens at
a distance to the mucosal surface (Hansson and Johansson, 2010;
Hooper andMacpherson,2010).However, it is now clear that there
is also constant communication between microbial cells or signals
and host cell receptors, and that many of these interactions lead to
the development of immune tolerance toward bacterial antigens
(Hooper and Macpherson, 2010; Geuking et al., 2011).
Traditionally, it has been accepted that the evolution of the
mammalian immune system has been driven by selective pressures
imposed by pathogenic bacteria (Matsunaga and Rahman, 1998).
For example, the emergence of jaws in cartilaginous ﬁsh matches
the appearance of antigen receptor speciﬁcity and immunological
memory in B and T cells, as well as the major histocompatibil-
ity complexes (MHC) I and II, all characteristic of the adaptive
immune system (Agrawal et al., 1998). Immunologists have spec-
ulated that the jaw gave organisms the ability to ingest harder
food sources that could damage the gut mucosa, likely increas-
ing their risk for infections. The nutritional advantages of having
a jaw allowed organisms to augment their body size and life
expectancy, increasing their risk for repeated microbial attack and
the necessity to develop immunological memory (Matsunaga and
Rahman, 1998). While this may be true for the emergence of
some features of the adaptive immune system, this view may not
apply to many other components of the immune system. First,
it does not take into account that the vast majority of inter-
actions that occur between the microbiota and the mammalian
immune system involve non-pathogenic bacteria. More impor-
tantly, commensals, as opposed to pathogens, do not limit the
host’s lifespan, reproducibility, and consequent vertical gene trans-
fer, and actually probably enhance it. Thus, it is more likely that
commensalmicroorganisms pose a stronger evolutionary pressure
on the host’s immune system than pathogens, a view that we share
with others (McFall-Ngai, 2007; Lee and Mazmanian, 2010).
The goal of this minireview is to describe some of the diverse
mechanisms of commensal–host communication in the mam-
malian intestine and to explore the effect that these have in
immune homeostasis within the intestine and systemically.
IMMUNE CONSEQUENCES OF AN AXENIC LIFE
The generation of germ-free mice has given us great insight into
the immune effects of a microbe-free life, the development of
the immune system during early microbial colonization, and the
effects of speciﬁc bacterial groups and species on the local and
systemic immune system.
The immune system is poorly developed in the absence of
microbes. Structurally, the aggregated lymphoid structures of the
GALT: mesenteric lymph nodes (MLNs), isolated lymphoid fol-
licles, cryptopatches, and Peyer’s patches are all underdeveloped
in germ-free mice (Mazmanian et al., 2005; Bouskra et al., 2008).
These mice exhibit decreased amounts of most cytokines, CD4+
T helper cells, FoxP3+ Tregs, B cells, Th17 cells, IgA, antimicrobial
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peptides, MHC class II, etc. (Moreau et al., 1978; Dobber et al.,
1992; Strauch et al., 2005; Ivanov et al., 2008; Niess et al., 2008;
Gaboriau-Routhiau et al., 2009; Round and Mazmanian, 2009),
and inoculating them with a single species of bacteria can revert
many of these defects (Umesaki et al., 1995; Mazmanian et al.,
2005). Gut bacteria also have critical effects on the development of
intestinal epithelial cells (IECs). IECs are the ﬁrst cells to encounter
themicrobiota and are able to integratemostmicrobial signals and
dictate the tone of the immune response of the underlying lamina
propria immune cells (Rescigno, 2011). IECs express microbial
pattern recognition receptors (PRR) that bind to microbial sig-
nals and upregulate the expression of mucus, cytokines, and other
immune components (Rescigno, 2011). In the absence of bacteria,
not only do these cells have a low expression of PRRs (Willing and
Van Kessel, 2007), they also fail to develop their typical microvilli
pattern and show a slow cell turnover rate (Abrams et al., 1963).
Not surprisingly, the functionality of the immune system in
axenic mice is very poor as well. Germ-free and even mono-
colonized mice do not develop oral tolerance (Rask et al., 2005).
Germ-free mice and antibiotic-treated mice are signiﬁcantly more
susceptible to infectious disease from several intestinal pathogens,
including Shigella ﬂexneri (Sprinz et al., 1961), Citrobacter roden-
tium (Wlodarska et al., 2011), Listeria monocytogenes (Zachar and
Savage, 1979), and Salmonella typhimurium (Nardi et al., 1989;
Sekirov et al., 2008; Ferreira et al., 2011). The microbiota can pre-
vent or ameliorate infection by direct microbial antagonism or by
indirectly promoting appropriate host immune defenses. Direct
microbial effects, also deﬁned as “colonization resistance” (van
der Waaij et al., 1971), include host receptor and nutrient com-
petition, and secretion of antimicrobial substances (Sekirov and
Finlay, 2009). The importance of these effects were demonstrated
in a study where transfer of a normal microﬂora, in the absence
of T and B cells, cleared infection with S. typhimurium (Endt
et al., 2010). This study highlights the importance of the compet-
itive pressures exerted by the microbiota as well as the role of the
innate immune response in enteric infections. In another study,
a fecal transplant from a mouse strain resistant to C. rodentium
was sufﬁcient to delay pathogen colonization and reduce mortal-
ity in a mouse strain lethally susceptible to infection. In addition,
antibiotic therapy increased disease severity in resistance mice,
suggesting that the difference in infection susceptibility between
the twomice strains can be explained, at least in part, by differences
in microbiota composition (Willing et al., 2011).
A normal microbiota has also been shown to help clear
pathogens by stimulating several host immune effectors. In one
study, oral treatment with peptidoglycan from the intestinal
microbiota was effective in preventing pneumococcal sepsis in
mice. Levels of this bacterial membrane component in serum cor-
related with systemic neutrophil killing capacity and activation of
the innate immune receptor NOD1, indicating that signals from
themicrobiota translocate across the intestinal barrier and interact
with systemic immune cells (Clarke et al., 2010). Another example
of how microbial-derived signals regulate the systemic immune
response comes from a study that showed that administration
of the TLR5 ligand, ﬂagellin, to antibiotic-treated mice inhib-
ited colonization with vancomycin resistant Enterococcus (VRE).
Intraperitoneal injection of ﬂagellin upregulated the expression of
the bactericidal lectinREGIIIγ in IECs andPaneth cells in the small
intestine via activation of TLR5 in hematopoietic cells and secre-
tion of IL-22 (Kinnebrew et al., 2010). Flagellin stimulation has
also been shown to induce differentiation of non-speciﬁc IgA+
plasma cells via activation of TLR5 in intestinal dendritic cells
(Uematsu et al., 2008). Colonization with the microorganism Bac-
teroides fragilis is sufﬁcient to prevent murine experimental colitis
induced by Helicobacter hepaticus. B. fragilis is coated with poly-
saccharide A (PSA) and this capsular component was shown to
suppress IL-17, increase IL-10 production and ameliorate disease
in this model (Mazmanian et al., 2008).
THE COMMENSAL MICROBIOTA BALANCES PRO AND
ANTI-INFLAMMATORY IMMUNE MECHANISMS
The Th17 immune response provides a good example of how
the microbiota mediates the balance between immune home-
ostasis and uncontrolled inﬂammation. Overproduction of Th17
cytokines IL-17 and IL-23 is associated with colitis (Atarashi et al.,
2008; Buonocore et al., 2010) and autoimmunity (Wen et al.,
2008; Lee et al., 2010; Wu et al., 2010); however, Th17 cells are
critical in controlling extracellular bacterial and fungal infections
(Smith et al., 2007; Wu et al., 2010). Induction of Th17 immu-
nity is crucial to prevent infection with C. rodentium, a murine
pathogen that induces similar inﬂammation to enteropathogenic
E. coli in humans (Wu et al., 2010). Thus, the right intensity of
Th17 response must be achieved in order to prevent microbial
attack and avoid uncontrolled inﬂammation. Segmented ﬁlamen-
tous bacteria (SFB) are an unclassiﬁed species that resides in the
murine ileum and has been shown to be a potent stimulator of the
Th17 response (Gaboriau-Routhiau et al., 2009; Wu et al., 2010).
Colonization with SFB induced the upregulation of cytokines,
antimicrobial peptides, and serum amyloid A (SAA), an acute
phase protein secreted during inﬂammation. SAA is believed to
promote the Th17 differentiation of CD4+ T cells (Ivanov et al.,
2009; Ather et al., 2011). Another mechanism that leads to Th17
differentiation is the production of commensal-derived adenosine
5′ triphosphate (ATP). ATP in the lamina propria stimulates den-
dritic cells to produce IL-6 and TGF-β, two cytokines necessary
for Th17 cell expansion (Atarashi et al., 2008). Not surprisingly,
microbial signals are also involved in limiting the Th17 immune
response. IECs produce IL-25, which inhibits IL-23 production
and prevents Th17 differentiation in response to the commensal
ﬂora (Zaph et al., 2008). In addition, oral administration of puri-
ﬁed PSA from B. fragilis downregulated the Th17 response and
induced propagation of Tregs in mice that develop autoimmune
encephalomyelitis. This treatment was sufﬁcient to prevent disease
in this animal model (Ochoa-Reparaz et al., 2010). Collectively,
these ﬁndings show how the microbiota produces inﬂammatory
and tolerogenic signals in order to achieve immune homeostasis,
a state that is favorable for both the microbiota and the host.
It is still unknown how certain microbes induce a pro-
inﬂammatory response and others a tolerogenic one, but due to
the central role that Treg cells have in regulating inﬂammatory
responses (Figure 1), one could speculate that microbes manip-
ulate the Treg cell response as a strategy to regulate immune
responses towards them. But how do Treg cells perform such task?
These cells are selected in the thymus for their ability to suppress
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FIGURE 1 |The microbiota helps to maintain immune
homeostasis by stimulating different arms of theT cell response.
(A) SFB is a potent inducer of Th17 cells, whereas pathogens like S.
typhimurium induce an effector Th1 response. PSA from B. fragilis
stimulates the differentiation of FoxP3+T cells, which downregulate
the pro-inﬂammatory Th1 andTh17 responses. (B) Different
environmental and host-derived factors are known to cause dysbiosis.
Imbalances in the intestinal microbiota can favor Th17
pro-inﬂammatory T cells over regulatory FoxP3+T cells, inducing
inﬂammatory response that can damage the intestinal epithelium. In
a genetically predisposed host this can lead to chronic inﬂammatory
disease, such as IBD or autoimmunity.
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T cells with a high afﬁnity to self-MHC molecules, thus prevent-
ing autoimmune responses, but it is still unknown how these cells
differentiate between pathogens or commensal pathogen signals.
One explanation may be that the antigens from the commensal
microbiota are used to train naïve T cells to differentiate into Treg
cells. A recent study provides evidence that this may in fact occur.
Analysis of several repertoires of T cell receptor (TCR) α chain
revealed that the TCRs from FoxP3+ Treg cells within the colonic
lamina propria are highly heterogeneous compared to Treg cells
from effector/memory T cells in the lamina propria and from
Treg cells from secondary lymphoid organs. Moreover, the study
showed that the mouse microbiota was essential for the induction
of this particular populationof colonicTreg cells fromnaïveT cells,
implying that there may be post-thymic mechanisms of immune
cell education that occur peripherally via interactions with the
commensal microbiota (Lathrop et al., 2011). This implies that
the immune system may have evolved to rely on the microbiota to
complete the training of a speciﬁc population of immune cells.
DISSECTING THE GUT MICROBIOTA
Although our knowledge of the immune effects caused by the
microbiota is growing, much less is known about what constitutes
a normal microbiota and which groups of microorganisms are
beneﬁcial or detrimental to immune homeostasis. Sequencing-
based studies have substantially increased our knowledge of the
ecology of the mammalian intestine, although it is safe to assume
that we are likely at the early stages of comprehending this complex
population.
Analyses of the human gut microbiota have yielded several
important ﬁndings. First, although there is great inter-individual
variability at the species level, there appears to be low variabil-
ity between individuals at the phylum level (Eckburg et al., 2005;
Turnbaugh et al., 2009). The human gut is colonized by mainly
three phyla: Firmicutes, Bacteroidetes, and Actinobacteria. The
most predominant bacterial families are Ruminococcaceae, Lach-
nospiraceae, Eubacteriaceae, and Bacteroidaceae, in what has been
deﬁned as the “core members of the microbiota” (Tap et al.,
2009). Genetics and environmental factors, such as birth deliv-
ery method, diet, and antibiotic use have an important role in
establishing the composition of the microbiota (Ley et al., 2006;
Penders et al., 2006; Adlerberth, 2008; Benson et al., 2010; Willing
et al., 2010). Compositional studies have also shown that cer-
tain members of the ﬂora may be indicative of disease states.
For example, the bacterium Faecalibacterium prausnitzii, a mem-
ber of the Ruminococcaceae family is absent in samples from
Crohn’s disease (CD) patients (Sokol et al., 2008; Willing et al.,
2009). Moreover, amelioration of disease with the anti TNF anti-
body, inﬂiximab, allows F. prausnitzii to recolonize (Swidsinski
et al., 2008). Furthermore, F. prausnitzii levels do not change in
patients with ulcerative colitis, a disease characterized by Th2-
type inﬂammation, suggesting that this microorganism is partic-
ularly susceptible to Th1 (predominant in CD) and not Th2-type
inﬂammation.
A recent study analyzed the human fecal microbiota of 39
individuals from 6 different developed countries and found
that there are three distinct ecosystems in the human gut,
or “enterotypes.” The genus Bacteroides is highly abundant in
enterotype 1, Prevotella is very common for enterotype type 2
and Ruminococcus in enterotype 3. Although the functional impli-
cations of all enterotypes are still under study, it seems that
each enterotype favors the synthesis of certain metabolic prod-
ucts. Enterotype 1 ecosystem favors the production of enzymes
involved in biotin synthesis, whereas enterotype 2 species pro-
duce more enzymes for thiamine synthesis (Arumugam et al.,
2011). Another study examined the fecal microbiota of 98 indi-
viduals and showed that samples clustered into two of the previ-
ously described enterotypes: Bacteroides-rich and Prevotella-rich
ecosystems. Interestingly, the authors were able to correlate these
enterotypes with long-term diets. Individuals with high animal
fat in their diet clustered in the Bacteroides enterotype, whereas
diets high in carbohydrate clustered in the Prevotella enterotype.
A short-term intervention with a carbohydrate-rich diet did not
cause a switch from Bacteroides into Prevotella enterotypes, sug-
gesting that they reﬂect long-term diet conditions (Wu et al.,
2011). There are still many unanswered questions regarding the
correlation between intestinal enterotypes and the immune sta-
tus of the host, as well as the possibility that there are more than
three enterotypes or subenterotypes. However, the compositional
classiﬁcation of the human gut microbiota into functional ecosys-
tems has enormous potential as a marker of disease and as a
treatment.
FINAL REMARKS
The immune environment of the gut is characterized by toler-
ance. To achieve this state, host immune cells must learn to exhibit
a tolerogenic behavior toward most microbial antigens. Thus,
besides protecting the host from microbial attack, post-natal bac-
terial colonization likely serves the immune system with another
important function: to be used as the second “training ground”
for some naïve immune cells. Although this view poses a caveat
to the traditional view of the main function of immune system –
to distinguish between self and non-self – it may explain why
the majority of the bacterial antigens in the gut are perceived as
self-antigens.
More mechanisms on how and what components of the com-
mensal microbiota affect mucosal and systemic immunity will
undoubtedly continue to be found. This will not only expand our
view of our microbiota as an integral part of our bodies (Gill et al.,
2010), but it also opens the real possibility of manipulating spe-
ciﬁc functions of themicrobiota to tune immunedefects that cause
infectious, inﬂammatory, or autoimmune disease. Learning from
the strategies that the microbiota use to balance the different arms
of the immune response and using them to overcome disease may
prove to be more efﬁcient than modifying the immune imbalances
that originate from defective genes and microbial dysbiosis.
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